INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
DP
Damani PriteshChief Technology Officer
REAXReal REMAX Group Inc.
Option exercise
M—
1,285 sh
Sep 13, 2026Sep 15, 2026
Page 355 of 1689
← PrevNext →
traded Sep 13, 2026
+2d
SEC Form 4

Evidence

13
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
4,483 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,800
40 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
MA
Maddison John AnthonyChief Product Mkting Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$83K
204 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
80 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
LA
Lumpkin AlexandraChief Legal Officer
REAXReal REMAX Group Inc.
Option exercise
M—
304 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

12
TG
Thomas Andrew GChief Experience Officer
KFRCKFORCE INC
Other acquisition or disposition
J—
338 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

12
MR
Mehl RandallDirector
KFRCKFORCE INC
Other acquisition or disposition
J—
235 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

12
BD
Brooks Derrick DewanDirector
KFRCKFORCE INC
Other acquisition or disposition
J—
38 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

12
BD
Brooks Derrick DewanDirector
KFRCKFORCE INC
Other acquisition or disposition
J—
83 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

12
CC
Cloudman CatherineDirector
KFRCKFORCE INC
Other acquisition or disposition
J—
64 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

11
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$237K
15.2K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

11
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$334K
13.2K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

11
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$225K
3,785 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

11
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$249K
2,800 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

10
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Option exercise
M—
122.3K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
FR
Farnsworth RussellChief Accounting Officer
SSRMSSR MINING INC.
Grant or award
A—
15 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
SJ
Sparks Michael JohnChief Financial Officer
SSRMSSR MINING INC.
Grant or award
A—
70 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
MM
Mullen Laura MDirector
SSRMSSR MINING INC.
Grant or award
A—
10 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
RJ
Rozenblat JennaPresident
REAXReal REMAX Group Inc.
Option exercise
M—
914 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

9
MD
Malchuk DanielDirector
SSRMSSR MINING INC.
Grant or award
A—
31 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
EJ
Ebbett JohnEVP, Growth and Innovation
SSRMSSR MINING INC.
Grant or award
A—
57 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
DP
Damani PriteshChief Technology Officer
REAXReal REMAX Group Inc.
Option exercise
M—
1,285 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

9
MK
MacNevin William K.EVP, Ops & Sustainability
SSRMSSR MINING INC.
Grant or award
A—
106 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
HD
Higgs Stephen DaleSVP
SYYSYSCO CORP
Tax withholding
F$14K
176 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
OJ
Onyia JudeChief Scientific Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
3,587 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
MJ
Malm JoshuaChief Financial Officer
FEAM5E Advanced Materials, Inc.
Tax withholding
F$1,544
1,225 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
RD
Realmuto Nicholas DanielSVP, Controller
NMIHNMI Holdings, Inc.
Tax withholding
F—
302 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

9
GK
Green KristenDirector
GAPGAP INC
Grant or award
A—
9,055 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
VH
Vousden Karen HDirector
FTHFaeth Therapeutics, Inc.
Grant or award
A—
25.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
DD
Dornan DavidChief Scientific Officer
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
85.9K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
WW
Weibel Paul Wesley IIIChief Executive Officer
FEAM5E Advanced Materials, Inc.
Grant or award
A—
795 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
MD
Malchow Eric DennisDirector, President & Global Head of M&A, 10% Owner
LCLNLincoln International, Inc.
Grant or award
A—
634 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
HP
Hill Jesse P.Chief Financial Officer
AGNTAGNT, Inc.
Tax withholding
F$1,369
333 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

9
SJ
Sparks Michael JohnChief Financial Officer
SSRMSSR MINING INC.
Grant or award
A—
106 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
DM
Dugan MargaretChief Medical Officer
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
81.3K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
MM
Marvin Kristin MarieGeneral Counsel
LCLNLincoln International, Inc.
Grant or award
A—
71 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
ER
Edens Wesley RDirector, Chief Executive Officer, 10% Owner
NFENew Fortress Energy Inc.
Grant or award
A—
48.3K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
SA
Swager Karen ADirector
SSRMSSR MINING INC.
Grant or award
A—
73 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
BH
Bailey Michael HEVP, Chief Financial Officer
FGF&G Annuities & Life, Inc.
Grant or award
A—
26.8K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence